TY - JOUR
T1 - Diagnostic thresholds with three ordinal groups
AU - Attwood, Kristopher
AU - Tian, Lili
AU - Xiong, Chengjie
N1 - Funding Information:
Dr. Xiong’s research was partly supported by National Institute on Aging (NIA) grants P50 AG05681, P01 AG03991, P01 AG26276, R01 AG029672, and R01 AG034119.
PY - 2014/5/4
Y1 - 2014/5/4
N2 - In practice, there exist many disease processes with three ordinal disease classes; for example, in the detection of Alzheimers disease (AD) a patient can be classified as healthy (disease-free stage), mild cognitive impairment (early disease stage), or AD (full disease stage). The treatment interventions and effectiveness of such disease processes will depend on the disease stage. Therefore, it is important to develop diagnostic tests with the ability to discriminate between the three disease stages. Measuring the overall ability of diagnostic tests to discriminate between the three classes has been discussed extensively in the literature. However, there has been little proposed on how to select clinically meaningful thresholds for such diagnostic tests, except for a method based on the generalized Youden index by Nakas et al. (2010). In this article, we propose two new criteria for selecting diagnostic thresholds in the three-class setting. The numerical study demonstrated that the proposed methods may provide thresholds with less variability and more balance among the correct classification rates for the three stages. The proposed methods are applied to two real examples: the clinical diagnosis of AD from the Washington University Alzheimers Disease Research Center and the detection of liver cancer (LC) using protein segments.
AB - In practice, there exist many disease processes with three ordinal disease classes; for example, in the detection of Alzheimers disease (AD) a patient can be classified as healthy (disease-free stage), mild cognitive impairment (early disease stage), or AD (full disease stage). The treatment interventions and effectiveness of such disease processes will depend on the disease stage. Therefore, it is important to develop diagnostic tests with the ability to discriminate between the three disease stages. Measuring the overall ability of diagnostic tests to discriminate between the three classes has been discussed extensively in the literature. However, there has been little proposed on how to select clinically meaningful thresholds for such diagnostic tests, except for a method based on the generalized Youden index by Nakas et al. (2010). In this article, we propose two new criteria for selecting diagnostic thresholds in the three-class setting. The numerical study demonstrated that the proposed methods may provide thresholds with less variability and more balance among the correct classification rates for the three stages. The proposed methods are applied to two real examples: the clinical diagnosis of AD from the Washington University Alzheimers Disease Research Center and the detection of liver cancer (LC) using protein segments.
KW - Alzheimer's disease (AD)
KW - Generalized Youden index
KW - Optimal threshold
KW - ROC surface
KW - Transitional stage
UR - http://www.scopus.com/inward/record.url?scp=84898937193&partnerID=8YFLogxK
U2 - 10.1080/10543406.2014.888437
DO - 10.1080/10543406.2014.888437
M3 - Article
C2 - 24707966
AN - SCOPUS:84898937193
SN - 1054-3406
VL - 24
SP - 608
EP - 633
JO - Journal of Biopharmaceutical Statistics
JF - Journal of Biopharmaceutical Statistics
IS - 3
ER -